Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)
[🇬🇧 – ENG] – We’re proud to announce a new partnership with Pierre Fabre Group!
Committed to acting alongside patients, Pierre Fabre takes another step towards giving them the possibility to play a more active role in caring for their health. We’re happy to align in our mission towards patient empowerment.
More details coming soon!
—–
[🇪🇸 – ES] – Estamos muy orgullosos de anunciar una nueva colaboración con Pierre Fabre.
Comprometidos en acompañar siempre a los pacientes, Pierre Fabre da un paso más ofreciéndoles la posibilidad de adoptar un papel más activo en el cuidado de su salud. Estamos contentos de compartir nuestra misión a través del empoderamiento del paciente.
¡Pronto os daremos más detalles!
After taking Vik Atopic Dermatitis to 9 countries and in four different languages, our main goal remains guiding patients through their search for a healthier life.
Telemedicine at the service of patients 🚀
We’re proud to announce a partnership with TeleClinic, Germany’s market leader for online consultations.
🇺🇸 After expanding to six countries this year, Vik Atopic Dermatitis completes the world tour with one more launch: the USA!
We are proud to announce the launch of Vik Colorectal in Spain! Developed with the institutional support of Pierre Fabre Group, our newest virtual companion will support patients and their loved ones living with colorectal cancer!